VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,050,000 | +8.7% | 32,779 | 0.0% | 0.69% | +34.0% |
| Q3 2021 | $966,000 | -13.3% | 32,779 | 0.0% | 0.52% | -22.4% |
| Q2 2021 | $1,114,000 | +4.6% | 32,779 | 0.0% | 0.67% | -14.4% |
| Q1 2021 | $1,065,000 | -61.8% | 32,779 | -36.2% | 0.78% | -72.0% |
| Q4 2020 | $2,785,000 | -34.7% | 51,340 | -33.3% | 2.78% | -41.7% |
| Q3 2020 | $4,263,000 | +34.8% | 77,010 | +20.8% | 4.76% | -18.2% |
| Q2 2020 | $3,162,000 | +243.0% | 63,776 | +59.4% | 5.82% | +179.5% |
| Q1 2020 | $922,000 | -28.8% | 40,000 | -29.1% | 2.08% | +140.5% |
| Q3 2017 | $1,295,000 | +4.0% | 56,400 | 0.0% | 0.87% | +35.3% |
| Q2 2017 | $1,245,000 | -3.2% | 56,400 | 0.0% | 0.64% | -39.5% |
| Q1 2017 | $1,286,000 | +9.0% | 56,400 | 0.0% | 1.06% | +44.9% |
| Q4 2016 | $1,180,000 | -20.9% | 56,400 | 0.0% | 0.73% | +27.0% |
| Q3 2016 | $1,491,000 | – | 56,400 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |